Switch/Sucrose Non-Fermentable (SWI/SNF) Complex—Partial Loss in Sinonasal Squamous Cell Carcinoma: A High-Grade Morphology Impact and Progression
Authors:
- Roberto Onner Cruz-TapiaRCRoberto Onner Cruz-Tapia
- Ana María Cano-ValdezACAna María Cano-Valdez
- Abelardo Meneses-GarcíaAMAbelardo Meneses-García
- Lorena Correa-ArzateLCLorena Correa-Arzate
- Adriana Molotla-FragosoAMAdriana Molotla-Fragoso
- Guillermo Villagómez-OleaGVGuillermo Villagómez-Olea
- Diana Brisa Sevilla-LizcanoDSDiana Brisa Sevilla-Lizcano
- Javier Portilla-RobertsonJPJavier Portilla-Robertson
Open Access
- 30 October 2024
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (11) , 12183-12195
Abstract
Sinonasal carcinomas are aggressive neoplasms that present a high morbidity and mortality rate with an unfavorable prognosis. This group of tumors exhibits morphological and genetic diversity. Genetic and epigenetic alterations in these neoplasms are the current targets for diagnosis and treatment. The most common type of cancer originating in the sinonasal tract is sinonasal squamous cell carcinomas (SNSCCs), which present different histological patterns and variable histological aggressiveness. A significant number of alterations have been reported in sinonasal tumors, including deficiencies in the Switch/Sucrose non-fermentable (SWI/SNF) chromatin remodeling complex. In the sinonasal tract, deficiencies of the subunits SMARCB1/INI1, SMARCA4/BRG1, and SMARCA2 have been noted in carcinomas, adenocarcinomas, and soft tissue tumors with a distinctive high-grade morphology and a fatal prognosis. Objective: The objective of this study is to identify the status of the SWI/SNF complex using immunohistochemistry in sinonasal squamous cell carcinomas and their association with morphology and survival. Methods: A total of 103 sinonasal carcinomas with different grades of squamous differentiation were analyzed; the selection was based on those cases with high-grade morphology. The carcinomas were then evaluated immunohistochemically for SMARCB1 and SMARCA4 proteins. Their expression was compared with the biological behavior and survival of the patients. Results: Among the SNSCCs, 47% corresponded to the non-keratinizing squamous cell carcinoma (NKSCC) type with high-grade characteristics, 40% were keratinizing squamous cell carcinomas (KSCCs), 9% were SMARCB1-deficient carcinomas, and 4% were SMARCA4-deficient carcinomas. Mosaic expression for SMARCB1 (NKSCC—33%; KSCC—21.9%) and SMARCA4 (NKSCC—14.6%; KSCC—12.2%) was identified, showing an impact on tumor size and progression. Conclusions: We identified that that the partial loss (mosaic expression) of SMARCB1 in SNSCCs is associated with high-grade malignant characteristics and a negative effect on patient survival; meanwhile, SMARCA4-mosaic expression in SNSCCs is associated with high-grade malignant characteristics and an increase in tumor size concerning the intact SMARCA4.Keywords
All Related Versions
Funding Information
- National Council of Humanities, Sciences and Technology (CONAHCYT-CVU:643347)
This publication has 39 references indexed in Scilit:
- SMARCB1-deficient sinonasal adenocarcinoma: a rare variant of SWI/SNF-deficient malignancy often misclassified as high-grade non-intestinal-type sinonasal adenocarcinoma or myoepithelial carcinomaVirchows Archiv, 2023
- Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull BaseHead and Neck Pathology, 2022
- Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and TreatmentCurrent Oncology Reports, 2022
- SWI/SNF‐deficient undifferentiated malignancies: where to draw the line†The Journal of Pathology, 2021
- SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological FeaturesHead and Neck Pathology, 2020
- Novel Biomarkers in Sinonasal Cancers: from Bench to BedsideCurrent Oncology Reports, 2020
- A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomasChild's Nervous System, 2017
- OSPs and ESPs and ISPs, Oh My! An Update on Sinonasal (Schneiderian) PapillomasHead and Neck Pathology, 2017
- SMARCA4-deficient Sinonasal CarcinomaHead and Neck Pathology, 2017
- Incidence and survival in patients with sinonasal cancer: A historical analysis of population‐based dataHead & Neck, 2011